A recent case report highlights the diagnostic challenges and potentially severe visual consequences of pituitary apoplexy, emphasizing the need for rapid recognition and treatment when patients present with acute headache and visual disturbances.
Pituitary apoplexy is a rare but life-threatening endocrine emergency caused by hemorrhage or infarction within the pituitary gland, most often occurring in the setting of a pituitary adenoma. The condition can produce sudden neurological, ophthalmologic, and endocrine symptoms, including severe headache, visual impairment, and altered consciousness.
The report describes the case of a 56-year-old woman who presented to a neurology clinic with sudden visual loss and severe headache after several years of progressive symptoms. She had experienced blurred vision for approximately three years and worsening headaches for more than two years before imaging revealed a pituitary adenoma measuring approximately 3 × 2 cm. Although she had been referred for neurosurgical evaluation at that time, she did not pursue follow-up care.
One week before presenting to the clinic, the patient experienced an acute loss of vision accompanied by projectile vomiting. Examination showed stable vital signs but revealed bitemporal hemianopia on confrontation visual field testing. Further evaluation with CT imaging identified a cystic mass in the sella turcica measuring approximately 4.6 × 2.7 cm that compressed the optic chiasm – findings consistent with pituitary apoplexy.
Visual field testing confirmed profound visual impairment. The patient had no perception of light in the left eye, while the right eye showed temporal visual field loss. Optical coherence tomography findings supported the presence of optic nerve damage associated with a mass in the sellar region.
The patient was initially treated with high-dose corticosteroids to address endocrine instability and inflammation. Although her headaches improved, visual deficits persisted. She subsequently underwent endoscopic transsphenoidal resection of the pituitary tumor. During surgery, clinicians identified hemorrhagic tumor contents and removed the fibrous capsule. Histopathology confirmed pituitary adenoma.
Postoperatively, the patient experienced partial visual recovery, regaining vision in the right eye and the ability to count fingers within two days of surgery. However, vision in the left eye did not recover. Follow-up endocrine testing showed improvement in thyroid function parameters, although adrenocorticotropic hormone levels remained low.
Pituitary apoplexy can have a mortality rate of up to 15.3% if not promptly treated. The syndrome commonly causes visual impairment due to compression of the optic chiasm and may also lead to deficiencies in anterior pituitary hormones – most frequently ACTH.
The case report authors stress that early diagnosis and rapid intervention are essential to preserving vision and preventing long-term complications. Clinicians should consider pituitary apoplexy in patients with known pituitary adenoma who develop sudden severe headaches or visual field defects. Prompt imaging, endocrine evaluation, and multidisciplinary management – including neurosurgical care – may significantly improve patient outcomes.
Source: Clinical Case Reports.
